🇺🇸 FDA
Pipeline program

shenhuang granule

2024-KLS-234-02

Phase 1 small_molecule active

Quick answer

shenhuang granule for Sepsis is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Sepsis
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials